The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.
Orthologous CRISPR–Cas9 enzymes for combinatorial genetic screens
Open accessAbstract
Combinatorial genetic screening using CRISPR-Cas9 is a useful approach to uncover redundant genes and to explore complex gene networks. However, current methods suffer from interference between the single-guide RNAs (sgRNAs) and from limited gene targeting activity. To increase the efficiency of combinatorial screening, we employ orthogonal Cas9 enzymes from Staphylococcus aureus and Streptococcus pyogenes. We used machine learning to establish S. aureus Cas9 sgRNA design rules and paired S. aureus Cas9 with S. pyogenes Cas9 to achieve dual targeting in a high fraction of cells. We also developed a lentiviral vector and cloning strategy to generate high-complexity pooled dual-knockout libraries to identify synthetic lethal and buffering gene pairs across multiple cell types, including MAPK pathway genes and apoptotic genes. Our orthologous approach also enabled a screen combining gene knockouts with transcriptional activation, which revealed genetic interactions with TP53. The "Big Papi" (paired aureus and pyogenes for interactions) approach described here will be widely applicable for the study of combinatorial phenotypes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ECCITE-seq is readily applicable to any sgRNA library with the Cas9 S. pyogenes scaffold sequence and, by allowing direct capture of sgRNA molecules, overcomes documented problems of barcode swapping events observed with Perturb-seq that have the potential to confound single cell perturbation screens17–20.”
From Multiplexed detection of proteins, transcriptomes, clonotypes and CRISPR perturbations in single cells (2019) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., & Wang, X. (1997) · Cell · doi:10.1016/s0092-8674(00)80434-1 · Cited by 7,289
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
Doench, J. G., Fusi, N., Sullender, M., Hegde, M., Vaimberg, E. W., Donovan, K. F., Smith, I., Tothova, Z., Wilen, C., Orchard, R., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3437 · Cited by 4,637
Self-citationMitochondrial membrane permeabilization in cell death
Kroemer, G., Galluzzi, L., & Brenner, C. (2007) · Physiological Reviews · doi:10.1152/physrev.00013.2006 · Cited by 3,598
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,407
Discovery and saturation analysis of cancer genes across 21 tumour types
Lawrence, M. S., Stojanov, P., Mermel, C. H., Robinson, J. T., Garraway, L. A., Golub, T. R., Meyerson, M., Gabriel, S. B., Lander, E. S., & Getz, G. (2014) · Nature · doi:10.1038/nature12912 · Cited by 3,096
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Souers, A. J., Leverson, J. D., Boghaert, E. R., Ackler, S. L., Catron, N. D., Chen, J., Dayton, B. D., Ding, H., Enschede, S. H., Fairbrother, W. J., et al. (2013) · Nature Medicine · doi:10.1038/nm.3048 · Cited by 3,058
Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation
Gilbert, L. A., Horlbeck, M. A., Adamson, B., Villalta, J. E., Chen, Y., Whitehead, E. H., Guimaraes, C., Panning, B., Ploegh, H. L., Bassik, M. C., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.029 · Cited by 2,728
In vivo genome editing using Staphylococcus aureus Cas9
Ran, F. A., Cong, L., Yan, W. X., Scott, D. A., Gootenberg, J. S., Kriz, A. J., Zetsche, B., Shalem, O., Wu, X., Makarova, K. S., et al. (2015) · Nature · doi:10.1038/nature14299 · Cited by 2,687
Global Mapping of the Yeast Genetic Interaction Network
Tong, A. H. Y., Lesage, G., Bader, G. D., Ding, H., Xu, H., Xin, X., Young, J., Berriz, G. F., Brost, R. L., Chang, M., et al. (2004) · Science · doi:10.1126/science.1091317 · Cited by 2,089
Cited by
Sorted by citations
Items 101–200 of 283
Synthetic Lethal Networks for Precision Oncology: Promises and Pitfalls
Shen, J. P., & Ideker, T. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.06.026 · Cited by 27
Paralog Explorer: A resource for mining information about paralogs in common research organisms
Hu, Y., Ewen‐Campen, B., Comjean, A., Rodiger, J., Mohr, S. E., & Perrimon, N. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.11.041 · Cited by 28
Synthetic lethal gene pairs: Experimental approaches and predictive models
Tang, S., Gökbağ, B., Fan, K., Shao, S., Huo, Y., Wu, X., Cheng, L., & Li, L. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.961611 · Cited by 28
High-throughput genetic screens using CRISPR–Cas9 system
Kweon, J., & Kim, Y. (2018) · Archives of Pharmacal Research · doi:10.1007/s12272-018-1029-z · Cited by 27
Mekler, V. M., Kuznedelov, K. D., & Severinov, K. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.012239 · Cited by 29
Development of multiplexed orthogonal base editor (MOBE) systems
Cowan, Q. T., Gu, S., Gu, W., Ranzau, B. L., Simonson, T. S., & Komor, A. C. (2025) · Nature Biotechnology · doi:10.1038/s41587-024-02240-0 · Cited by 26
Pooled Genome-Scale CRISPR Screens in Single Cells
Schraivogel, D., Steinmetz, L. M., & Parts, L. (2023) · Annual Review of Genetics · doi:10.1146/annurev-genet-072920-013842 · Cited by 28
Deciphering pathogenicity of variants of uncertain significance with CRISPR-edited iPSCs
Guo, H., Liu, L., Nishiga, M., Cong, L., & Wu, J. C. (2021) · Trends in Genetics · doi:10.1016/j.tig.2021.08.009 · Cited by 32
Opportunities in biotechnology
Gartland, K. M. A., & Gartland, J. S. (2018) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2018.06.303 · Cited by 26
Multi-view graph convolutional network for cancer cell-specific synthetic lethality prediction
Fan, K., Tang, S., Gökbağ, B., Cheng, L., & Li, L. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2022.1103092 · Cited by 24
Walton, R. T., Qin, Y., Kirby, B., Andrews, J. O., Taipale, M., Kang, B., & Blainey, P. C. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.17.585235 · Cited by 27
Meyer, L. M., Koschade, S. E., Vischedyk, J. B., Thölken, M., Gubaš, A., Wegner, M., Başoğlu, M., Knapp, S., Kaulich, M., Eimer, S., et al. (2023) · Autophagy · doi:10.1080/15548627.2023.2230839 · Cited by 24
Generating, modeling and evaluating a large-scale set of CRISPR/Cas9 off-target sites with bulges
Yaish, O., & Orenstein, Y. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae428 · Cited by 24
Applications of CRISPR-Cas in Bioengineering, Biotechnology, and Translational Research
Lau, C. (2018) · The CRISPR Journal · doi:10.1089/crispr.2018.0026 · Cited by 22
Highly Combinatorial Genetic Interaction Analysis Reveals a Multi-Drug Transporter Influence Network
Celaj, A., Gebbia, M., Musa, L., Coté, A. G., Snider, J. D., Wong, V., Ko, M., Fong, T., Bansal, P., Mellor, J. C., et al. (2019) · Cell Systems · doi:10.1016/j.cels.2019.09.009 · Cited by 23
Synthetic lethality in cancer drug discovery: challenges and opportunities
Gonçalves, E., Ryan, C. J., & Adams, D. J. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01273-7 · Cited by 27
Designing custom CRISPR libraries for hypothesis-driven drug target discovery
Iyer, V. S., Jiang, L., Shen, Y., Boddul, S. V., Panda, S. K., Kasza, Z., Schmierer, B., & Wermeling, F. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.08.009 · Cited by 21
Re-defining synthetic lethality by phenotypic profiling for precision oncology
Akimov, Y. A., & Aittokallio, T. A. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.01.026 · Cited by 20
Hanna, R. E., & Doench, J. G. (2018) · Nature Biotechnology · doi:10.1038/nbt.4208 · Cited by 21
Self-citationAregger, M., Xing, K., & Gonatopoulos-Pournatzis, T. (2021) · Nature Protocols · doi:10.1038/s41596-021-00595-1 · Cited by 22
Engineering CRISPR/Cas9 therapeutics for cancer precision medicine
Sharma, A. K., & Giri, A. K. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1309175 · Cited by 23
Rhabdoid Tumors Are Sensitive to the Protein-Translation Inhibitor Homoharringtonine
Howard, T. P., Oberlick, E. M., Rees, M. G., Arnoff, T. E., Pham, M., Brenan, L., DoCarmo, M., Hong, A. L., Kugener, G., Chou, H.-C., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-2717 · Cited by 21
Yaish, O., Asif, M., & Orenstein, Y. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac157 · Cited by 19
Pulice, J. L., & Meyerson, M. M. (2023) · Molecular Cell · doi:10.1016/j.molcel.2025.03.001 · Cited by 24
Expanding the Scope of Bacterial CRISPR Activation with PAM-Flexible dCas9 Variants
Kiattisewee, C., Karanjia, A. V., Legut, M., Daniloski, Z., Koplik, S. E., Nelson, J., Kleinstiver, B. P., Sanjana, N. E., Carothers, J. M., & Zalatan, J. G. (2022) · ACS Synthetic Biology · doi:10.1021/acssynbio.2c00405 · Cited by 21
Developing SHP2-based combination therapy for KRAS-amplified cancer
Li, T., Kikuchi, O., Zhou, J. R., Wang, Y., Pokharel, B., Bastl, K., Gokhale, P. C., Knott, A., Zhang, Y., Doench, J. G., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.152714 · Cited by 20
Self-citationSeo, S.-Y., Min, S., Lee, S., Seo, J. H., Park, J., Kim, H. K., Song, M., Baek, D., Cho, S., & Kim, S. (2023) · Nature Methods · doi:10.1038/s41592-023-01875-2 · Cited by 21
CRISPR-Cas and CRISPR-based screening system for precise gene editing and targeted cancer therapy
Qin, M., Deng, C., Wen, L., Luo, G., & Meng, Y. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05235-2 · Cited by 20
Radioresistance, DNA Damage and DNA Repair in Cells With Moderate Overexpression of RPA1
Velegzhaninov, I. O., Belykh, E. S., Rasova, E. E., Pylina, Y. I., Шадрин, Д. М., & Klokov, D. Y. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00855 · Cited by 22
SLKB: synthetic lethality knowledge base
Gökbağ, B., Tang, S., Fan, K., Cheng, L., Yu, L., Zhao, Y., & Li, L. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad806 · Cited by 19
The application of CRISPR/Cas9–based genome-wide screening to disease research
Chen, X., Zheng, M., Lin, S., Huang, M., Chen, S., & Chen, S. (2024) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2024.102004 · Cited by 21
Improved detection of differentially represented DNA barcodes for high‐throughput clonal phenomics
Akimov, Y. A., Bulanova, D. R., Timonen, S., Wennerberg, K., & Aittokallio, T. A. (2020) · Molecular Systems Biology · doi:10.15252/msb.20199195 · Cited by 19
Context-dependent genetic interactions in cancer
Henkel, L., Rauscher, B., & Boutros, M. (2019) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2019.03.004 · Cited by 20
Recent advances in regenerative medicine
Rajpoot, K., Safavi, M., Sreeharsha, N., & Tekade, R. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814455-8.00011-6 · Cited by 18
CRISPR-based methods for high-throughput annotation of regulatory DNA
Klann, T. S., Black, J. B., & Gersbach, C. A. (2018) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2018.02.004 · Cited by 19
A multilineage screen identifies actionable synthetic lethal interactions in human cancers
Fong, S. H., Kuenzi, B. M., Mattson, N. M., Lee, J. J. Y., Sanchez, K. S., Bojorquez-Gomez, A., Ford, K. M., Munson, B. P., Licon, K., Bergendahl, S., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01971-9 · Cited by 18
Reproducibility metrics for context-specific CRISPR screens
Billmann, M., Ward, H. N., Aregger, M., Costanzo, M., Andrews, B., Boone, C. M., Moffat, J., & Myers, C. L. (2023) · Cell Systems · doi:10.1016/j.cels.2023.04.003 · Cited by 16
Chromatin complex dependencies reveal targeting opportunities in leukemia
Najm, F. J., DeWeirdt, P. C., Moore, M. M., Bevill, S. M., Farran, C. A. E., Macias, K. A., Hegde, M., Waterbury, A. L., Liau, B. B., van Galen, P., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36150-7 · Cited by 16
Self-citationSynthetic lethal connectivity and graph transformer improve synthetic lethality prediction
Fan, K., Gökbağ, B., Tang, S., Li, S., Huang, Y., Wang, L., Cheng, L., & Li, L. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae425 · Cited by 17
Covering the Combinatorial Design Space of Multiplex CRISPR/Cas Experiments in Plants
Huffel, K. V., Stock, M., Ruttink, T., & Bernard De Baets, C. (2022) · Frontiers in Plant Science · doi:10.3389/fpls.2022.907095 · Cited by 15
Analysis of combinatorial CRISPR screens with the Orthrus scoring pipeline
Ward, H. N., Aregger, M., Gonatopoulos-Pournatzis, T., Billmann, M., Ohsumi, T. K., Brown, K. R., Blencowe, B. J., Moffat, J., & Myers, C. L. (2021) · Nature Protocols · doi:10.1038/s41596-021-00596-0 · Cited by 17
Wang, J., Wen, Y., Zhang, Y., Wang, Z., Jiang, Y., Dai, C., Wu, L., Leng, D., He, S., & Bo, X. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.11.035 · Cited by 14
A next-generation dual guide CRISPR system for genetic interaction library screening
Burgold, T., Karakoç, E., Gonçalves, E., Barrio‐Hernandez, I., Dwane, L., Silva, R., Souster, E., Sharma, M., Beck, A., Koh, C. C., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-67256-9 · Cited by 13
AsCRISPR: A Web Server for Allele-Specific Single Guide RNA Design in Precision Medicine
Zhao, G., Li, J., & Tang, Y. (2020) · The CRISPR Journal · doi:10.1089/crispr.2020.0071 · Cited by 15
CRISPR Screens to Identify Regulators of Tumor Immunity
LaFleur, M. W., & Sharpe, A. H. (2021) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-070120-094725 · Cited by 16
Functional Genomics for Cancer Research: Applications In Vivo and In Vitro
O’Loughlin, T. A., & Gilbert, L. A. (2018) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030518-055742 · Cited by 14
Tálas, A., Huszár, K., Kulcsár, P. I., Varga, J. K., Varga, É., Tóth, E., Welker, Z., Erdős, G., Pach, P. F., Welker, Á., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa1220 · Cited by 13
Chen, Y., Cheng, M., Li, Y., Wang, L., Fang, L., Cao, Y., & Song, H. (2022) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2022.09.005 · Cited by 15
A dual sgRNA library design to probe genetic modifiers using genome-wide CRISPRi screens
Guna, A., Page, K. R., Replogle, J. M., Esantsi, T. K., Wang, M. L., Weissman, J. S., & Voorhees, R. M. (2023) · BMC Genomics · doi:10.1186/s12864-023-09754-y · Cited by 14
Common computational tools for analyzing CRISPR screens
Colic, M., & Hart, T. (2021) · Emerging Topics in Life Sciences · doi:10.1042/etls20210222 · Cited by 13
Wang, H., Zhou, J., Lei, J., Mo, G., Wu, Y., Liu, H., Pang, Z., Du, M., Zhou, Z., Paek, C., et al. (2024) · PLoS Biology · doi:10.1371/journal.pbio.3002619 · Cited by 17
Mapping the Genetic Interaction Network of PARP inhibitor ResponsePreprint
Simpson, D., Jia, L., Jing, Y., & Adamson, B. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.19.553986 · Cited by 16
Paralog-based synthetic lethality: rationales and applications
Xin, Y., & Zhang, Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1168143 · Cited by 12
Modular vector assembly enables rapid assessment of emerging CRISPR technologies
McGee, A. V., Liu, Y. V., Griffith, A. L., Szegletes, Z. M., Wen, B., Kraus, C., Miller, N. W., Steger, R. J., Velasco, B. E., Bosch, J. A., et al. (2024) · Cell Genomics · doi:10.1016/j.xgen.2024.100519 · Cited by 12
Self-citationCEBPA repression by MECOM blocks differentiation to drive aggressive leukemias
Fleming, T. J., Antoszewski, M., Lambo, S., Gundry, M. C., Piussi, R., Wahlster, L., Shah, S. B., Reed, F. E., Dong, K. D., Paulo, J. A., et al. (2025) · Blood · doi:10.1182/blood.2025028954 · Cited by 11
Large-scale datasets uncovering cell signalling networks in cancer: context matters
Sharma, S., & Petsalaki, E. (2019) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2019.05.001 · Cited by 10
HIF-2α drives an intrinsic vulnerability to ferroptosis in clear cell renal cell carcinomaPreprint
Zou, Y., Palte, M. J., Deik, A., Li, H., Eaton, J. K., Wang, W., Tseng, Y., Deasy, R., Alimova, M., Dančík, V., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/388041 · Cited by 11
Self-citationChemogenetic interactions in human cancer cells
Colic, M., & Hart, T. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.09.006 · Cited by 10
Alves, E., McLeish, E., Blancafort, P., Coudert, J. D., & Gaudieri, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.712722 · Cited by 10
Towards a CRISPeR understanding of homologous recombination with high-throughput functional genomics
Hayward, S. B., & Ciccia, A. (2021) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2021.08.006 · Cited by 9
Pathway-driven analysis of synthetic lethal interactions in cancer using perturbation screens
Karimpour, M., Totonchi, M., Behmanesh, M., & Montazeri, H. (2023) · Life Science Alliance · doi:10.26508/lsa.202302268 · Cited by 8
Çetin, R., Quandt, E., & Kaulich, M. (2021) · Cells · doi:10.3390/cells10020260 · Cited by 10
In Vivo Cancer-Based Functional Genomics
Li, C., & Kasinski, A. L. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.07.004 · Cited by 9
A systematic analysis of genetic interactions and their underlying biology in childhood cancer
Daub, J. T., Amini, S., Kersjes, D. J. E., Ma, X., Jäger, N., Zhang, J., Pfister, S. M., Holstege, F. C. P., & Kemmeren, P. (2021) · Communications Biology · doi:10.1038/s42003-021-02647-4 · Cited by 9
Akimov, Y. A., Bulanova, D. R., Abyzova, M. S., Wennerberg, K., & Aittokallio, T. A. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/622506 · Cited by 7
Anvar, N. E., Lin, C., Ma, X., Wilson, L., Steger, R., Sangree, A. K., Colic, M., Wang, S. H., Doench, J. G., & Hart, T. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.03.522655 · Cited by 8
Self-citationBillmann, M., Costanzo, M., Zhang, X., Hassan, A. Z., Rahman, M., Brown, K. R., Chan, K. S., Tong, A. H. Y., Pons, C., Ward, H. N., et al. (2026) · Cell · doi:10.1016/j.cell.2026.03.044 · Cited by 17
Shi, S., Yang, G., Yan, Q., Wan, S., Li, M., & Li, M. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70051 · Cited by 7
Lin, H.-K., Cheng, J., Wu, C., Hsieh, F., Dunlap, C. A., & Chen, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-06813-4 · Cited by 6
Genetic landscape of T cells identifies synthetic lethality for T-ALL
O’Meara, C. P., Guerri, L., Lawir, D.-F., Mateos, F., Iconomou, M., Iwanami, N., Soza‐Ried, C., Sikora, K., Siamishi, I., Giorgetti, O. B., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02694-x · Cited by 7
Synthetic Lethality in Lung Cancer—From the Perspective of Cancer Genomics
Shimomura, I., Yamamoto, Y., & Ochiya, T. (2019) · Medicines · doi:10.3390/medicines6010038 · Cited by 8
Girardi, E., Fiume, G., Goldmann, U., Sin, C., Müller, F., Lindinger, S., Sedlyarov, V., Srndic, I., Agerer, B., Kartnig, F., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.31.275818 · Cited by 7
Multi-locus CRISPRi targeting with a single truncated guide RNA
Moore, M. M., Wekhande, S., Issner, R., Collins, A., Cruz, A. J., Liu, Y. V., Javed, N. M., Casaní-Galdón, S., Buenrostro, J. D., Epstein, C. B., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56144-x · Cited by 6
Self-citationLu, Z., Ni, K., Wang, Y., Zhou, Y., Li, Y., Yan, J., Song, Q., Liu, M., Xu, Y., Yu, Z., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac458 · Cited by 6
Lentiviral Transduction-based CRISPR/Cas9 Editing of Schistosoma mansoni Acetylcholinesterase
Du, X., McManus, D. P., French, J. D., Sivakumaran, H., Johnston, R. L., Kondrashova, O., Fogarty, C. E., Jones, M. K., & You, H. (2023) · Current Genomics · doi:10.2174/1389202924666230823094608 · Cited by 6
Dou, Y., Ren, Y., Zhao, X., Jin, J., Xiong, S., Luo, L., Xu, X., Yang, X., Yu, J., Guo, L., et al. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108066 · Cited by 6
Computational Methods for Analysis of Large-Scale CRISPR Screens
Lin, X., Chemparathy, A., Russa, M. F. L., Daley, T., & Qi, L. S. (2020) · Annual Review of Biomedical Data Science · doi:10.1146/annurev-biodatasci-020520-113523 · Cited by 7
Tools for Decoding Ubiquitin Signaling in DNA Repair
Foster, B., Attwood, M., & Gibbs‐Seymour, I. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.760226 · Cited by 5
Fully accessible fitness landscape of oncogene-negative lung adenocarcinoma
Yousefi, M., Andrejka, L., Szamecz, M., Winslow, M. M., Petrov, D. A., & Boross, G. Z. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2303224120 · Cited by 4
Liao, C., Ttofali, F., Slotkowski, R., Denny, S. R., Cecil, T. D., Leenay, R. T., Keung, A. J., & Beisel, C. L. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/312421 · Cited by 6
Up, down, and out: optimized libraries for CRISPRa, CRISPRi, and CRISPR-knockout genetic screensPreprint
Sanson, K. R., Hanna, R. E., Hegde, M., Donovan, K. F., Strand, C., Sullender, M. E., Vaimberg, E. W., Goodale, A. B., Root, D. E., Piccioni, F., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/356626 · Cited by 6
Self-citationMimitou, E. P., Cheng, A. Y., Montalbano, A., Hao, S., Stoeckius, M., Legut, M., Roush, T., Herrera, A. M., Papalexi, E., Ouyang, Z., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/466466 · Cited by 7
Using graph-based model to identify cell specific synthetic lethal effects
Pu, M., Cheng, K., Li, X., Xin, Y., Wei, L., Jin, S., Zheng, W., Peng, G., Tang, Q., Zhou, J., et al. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.10.011 · Cited by 5
Optimized metrics for orthogonal combinatorial CRISPR screens
Çetin, R., Wegner, M., Luwisch, L., Saud, S., Achmedov, T., Süsser, S., Vera-Guapi, A., Müller, K., Matthess, Y., Quandt, E., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-34597-8 · Cited by 5
Stuttmann, J., Barthel, K., Martin, P., Ordon, J., Erickson, J. L., Herr, R., Ferik, F., Kretschmer, C., Berner, T., Keilwagen, J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.31.018671 · Cited by 5
A global genetic interaction map of a human cell reveals conserved principles of genetic networksPreprint
Billmann, M., Costanzo, M., Zhang, X., Hassan, A. Z., Rahman, M., Brown, K. R., Chan, K., Tong, A. H. Y., Pons, C., Ward, H. N., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.30.662193 · Cited by 5
Lee, S., & Nam, H. (2025) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbbio.2025.3631499 · Cited by 4
Barlan, K., Bhide, G. P., White, D. R., Lake, M. R., Lu, C., Rieder, S., Fan, L., & Hsieh, C.-L. (2023) · SLAS DISCOVERY · doi:10.1016/j.slasd.2023.10.004 · Cited by 4
Jin, W., Deng, Y., Marca, J. E. L., Lelliott, E. J., Diepstraten, S. T., Koenig, C., Tai, L., Snetkova, V., Dorighi, K. M., Hoberecht, L., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56282-2 · Cited by 4
Shuffle-Seq: En masse combinatorial encoding for n -way genetic interaction screensPreprint
Dixit, A. C., Kuksenko, O., Feldman, D., & Regev, A. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/861443 · Cited by 4
Samdal, H., Hegre, S. A., Chawla, K., Liabakk, N., Aas, P. A., Sporsheim, B., & Sætrom, P. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.10.430566 · Cited by 4
Automated Design of Oligopools and Rapid Analysis of Massively Parallel Barcoded Measurements
Hossain, A., Cetnar, D. P., LaFleur, T. L., McLellan, J. R., & Salis, H. M. (2024) · ACS Synthetic Biology · doi:10.1021/acssynbio.4c00661 · Cited by 3
Leveraging CRISPR/Cas9 in notable bacteria for the production of industrially valuable compounds
Karim, M. D., Abuhena, M., Rahman, L., & Al-Rashid, J. (2025) · Systems Microbiology and Biomanufacturing · doi:10.1007/s43393-024-00326-z · Cited by 4
Evaluation of Cas13d as a tool for genetic interaction mapping
Kassem, G. E., Hillmer, J., & Boettcher, M. (2025) · Nature Communications · doi:10.1038/s41467-025-56747-4 · Cited by 3
CRISPR screening in cancer stem cells
Wang, B., & Wong, A. S. L. (2022) · Essays in Biochemistry · doi:10.1042/ebc20220009 · Cited by 4
Methods and Techniques to Select Efficient Guides for CRISPR-Mediated Genome Editing in Plants
D’Orso, F., Forte, V., Baima, S., Possenti, M., Palma, D., & Morelli, G. (2023) · Springer eBooks · doi:10.1007/978-3-031-46150-7_6 · Cited by 3
HyCas9-12aGEP: an efficient genome editing platform for Corynebacterium glutamicum
Zhang, F., Wang, J., Li, C.-L., & Zhang, W.-G. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1327172 · Cited by 3
Decoding gene regulation with CRISPR perturbations
Oberlin, S., & McManus, M. T. (2024) · Nature Biotechnology · doi:10.1038/s41587-024-02222-2 · Cited by 3
Hebert, J. D., Tang, Y. J., Szamecz, M., Andrejka, L., Lopez, S. S., Petrov, D. A., Boross, G. Z., & Winslow, M. M. (2025) · Molecular Biology and Evolution · doi:10.1093/molbev/msaf023 · Cited by 4
Generation of Monoclonal iPSC Lines with Stable Cas9 Expression and High Cas9 Activity
Liao, J. Q., Zhou, G., & Zhou, Y. (2020) · Methods in molecular biology · doi:10.1007/7651_2020_304 · Cited by 3
Metadata
- Authors
- Najm, F. J., Strand, C., Donovan, K. F., Hegde, M., Sanson, K. R., Vaimberg, E. W., Sullender, M. E., Hartenian, E., Kalani, Z., Fusi, N., Listgarten, J., Younger, S. T., Bernstein, B. E., Root, D. E., & Doench, J. G.
- Affiliations
- Broad Institute (US)
- Microsoft Research New England (United States) (US)
- Corresponding author
- Doench, John G
- ORCID
- Venue
- Nature Biotechnology
- Published
- 2017-12-18
- Volume
- 36
- Issue
- 2
- Pages
- 179-189
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC5800952
- OpenAlex
- W2781417302
- Cited by
- 279
- References
- 54
- Citations by year
- 2026: 16 · 2025: 22 · 2024: 26 · 2023: 32 · 2022: 26 · 2021: 45 · 2020: 39 · 2019: 36 · 2018: 37
- FWCI
- 12.51
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- National Cancer Institute (DP1CA216873)
- National Institute of General Medical Sciences (T32GM007226)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- CRISPR/Cas9, SaCas9, SpCas9, single guide RNA design, dual targeting, synthetic lethality, MAPK signaling, apoptosis, TP53, transcriptional activation, lentiviral vectors
- MeSH terms
- Machine Learning, RNA, Guide, CRISPR-Cas Systems, Epistasis, Genetic, Genetic Testing, Humans, Staphylococcus aureus, Streptococcus pyogenes, Signal Transduction, Tumor Suppressor Protein p53, Apoptosis, Gene Targeting, Mitogen-Activated Protein Kinase Kinases, Gene Knockout Techniques, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review